A detailed history of Planning Capital Management Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Planning Capital Management Corp holds 2,698 shares of BMY stock, worth $156,484. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,698
Previous 3,313 18.56%
Holding current value
$156,484
Previous $138 Million 1.48%
% of portfolio
0.09%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$39.66 - $51.75 $24,390 - $31,826
-615 Reduced 18.56%
2,698 $140 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $160,614 - $191,657
3,313 New
3,313 $170 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Planning Capital Management Corp Portfolio

Follow Planning Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planning Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Planning Capital Management Corp with notifications on news.